RESEARCH
Participants
A double-blind, randomized controlled study evaluated a nonpharmacologic Vedic vibration therapy in 176 adults with chronic arthritis-related pain, stiffness, or limited movement.
Following the treatment, 127 of the 176 participants—approximately 72%—reported a 60% or greater reduction in pain. Sixty-four participants, or approximately 36%, reported complete relief of pain immediately after treatment.
In the control condition, 19 participants reported pain relief of 60% or more, while none reported complete pain relief.
The researchers also reported significant improvements in stiffness and range of motion among the smaller groups of participants who experienced those symptoms.
The study measured immediate responses following treatment. It did not evaluate whether the reported improvements continued over days, months, or years.
Arthritis can affect comfort, mobility, independence, and the ability to perform ordinary daily activities.
Although arthritis includes many different conditions, common symptoms may include:
The participants in this study had previously been diagnosed with arthritis affecting the peripheral joints or spine. They were also required to have active pain, stiffness, or restricted movement when they entered the study.
The participants reported having symptoms for an average of 10.5 years, although the duration ranged from one week to 41 years.
The study, titled “A Double Blind Randomized Controlled Trial of Maharishi Vedic Vibration Technology in Subjects With Arthritis,” was authored by Tony A. Nader, D. Edwards Smith, Michael C. Dillbeck, Volker Schanbacher, Susan L. Dillbeck, Philippe Gallois, Sophie Beall-Rougerie, Robert H. Schneider, Sanford I. Nidich, Gary P. Kaplan, and Steele Belok.
It was published online in Frontiers in Bioscience on April 1, 2001.
The study included 176 adults who had been diagnosed with a chronic arthritic condition of the joints or spine by a physician or specialist.
The participants included people with:
Participants were randomly assigned to receive either the arthritis-specific Vedic vibration treatment or an active control treatment first.
The study used an unusual active-control design.
The experimental treatment was administered by an expert trained to provide the Vedic vibration procedure associated with joint and spinal conditions.
The control procedure was administered by an expert trained to use the same general technology for a different type of condition, such as a respiratory, skin, gastrointestinal, or nervous-system concern.
Neither the participant nor the practitioner knew whether the assigned procedure was the arthritis-specific treatment or the control treatment.
Treatment sessions lasted between approximately 30 seconds and several minutes. Participants were evaluated immediately afterward.
Those who received the control procedure first could subsequently receive the arthritis-specific treatment. Participants who received the arthritis treatment first and experienced complete relief did not always receive the control procedure afterward.
A total of 127 of the 176 participants reported a reduction in pain of 60% or greater after receiving the arthritis-specific treatment.
This represents approximately 72% of the study group.
By comparison, 19 participants reported pain relief of 60% or greater following the control procedure.
Sixty-four participants reported complete relief of pain after the treatment.
This represented approximately 36% of the full study group.
No participants reported complete pain relief following the control procedure.
The researchers defined complete pain relief as the disappearance of pain throughout the participant’s range of movement immediately following treatment.
Twenty-four participants reported restricted range of motion before treatment.
Of those participants:
The difference between the treatment and control responses was statistically significant.
Twenty-one participants reported joint or spinal stiffness.
Of those participants:
The difference between the treatment and control responses was also statistically significant.
The study included 62 participants with painful conditions affecting peripheral joints, excluding the participants diagnosed with rheumatoid arthritis.
Among this group, 42 reported pain relief of 60% or greater, and 26 reported complete pain relief following treatment.
Seven participants reported relief of 60% or greater after the control procedure, while none reported complete relief.
The study included 110 participants with painful conditions affecting the spine.
Among these participants, 81 reported pain relief of 60% or greater, and 38 reported complete pain relief.
Eleven reported relief of 60% or greater following the control procedure, while none reported complete relief.
Four participants had previously been diagnosed with rheumatoid arthritis.
All four reported pain relief of 60% or greater after the arthritis-specific treatment. One reported relief of 60% or more following the control procedure.
Because this subgroup included only four people, it was too small to support meaningful conclusions about rheumatoid arthritis.
The procedure evaluated in the study was formally known as Maharishi Vedic Vibration Technology.
It was described as a nonpharmacologic modality within the broader Maharishi Vedic Medicine system.
According to the published paper, a trained practitioner used a technique involving specific Vedic sounds or vibrations associated with the condition being addressed. The practitioner directed attention toward the affected area while applying the procedure.
The treatment lasted from approximately 30 seconds to several minutes and did not involve medication, physical manipulation, or an invasive medical procedure.
This specialized intervention should not be confused with standard sound therapy, music therapy, massage, or a general Ayurvedic treatment. The study evaluated a specific method administered by practitioners trained in that system.
Participants rated changes in pain, stiffness, and range of motion using a scale from 0% to 100%.
A score of 0% indicated no improvement.
For pain, 100% meant that the participant reported no pain throughout the full range of movement.
For stiffness, 100% meant that the participant reported no remaining stiffness throughout the range of movement.
For range of motion, 100% meant that the participant was considered to have regained full movement.
Researchers and other trained evaluators also examined the participants before and after treatment. The correlation between participant pain ratings and evaluator assessments was reported as 0.82, indicating relatively strong agreement between the two evaluations.
The results are noteworthy because a substantial proportion of participants reported immediate reductions in chronic pain following a brief, nonpharmacologic procedure.
The differences between the arthritis-specific treatment and the active control procedure were statistically significant for pain, stiffness, and range of motion.
The use of an active control was also important. Participants in both conditions received what appeared to be the same general type of treatment, but the control procedure was intended for an unrelated condition.
This was designed to reduce the likelihood that the findings could be explained entirely by participant expectations or simply receiving attention from a practitioner.
However, the results represent immediate responses only. The study does not show whether the relief continued after participants left the treatment setting.
Although the study was randomized and double-blind, it had several significant limitations.
Pain, stiffness, and movement were graded using percentage estimates rather than widely used standardized arthritis assessment tools.
Range of motion was not measured with specialized instruments. Instead, participants and evaluators estimated the percentage of improvement.
The design also meant that not every participant completed both procedures. Participants who received the arthritis-specific treatment first and reported complete relief did not necessarily receive the control treatment.
The research measured symptoms immediately after a very brief treatment. It did not include a long-term follow-up to determine whether the reported relief continued.
Only four participants had rheumatoid arthritis, making it impossible to draw dependable conclusions about that specific disease.
The study did not evaluate changes in inflammation, joint damage, disease progression, medication use, surgery rates, or long-term physical functioning.
The researchers reported that no side effects were observed during the study, but the brief observation period was not sufficient to establish comprehensive safety.
Additional independently conducted studies using standardized outcomes, conventional control groups, and long-term follow-up would be needed to confirm the findings.
The results should not be interpreted as evidence that this treatment cures arthritis or can replace appropriate medical care.
Nader TA, Smith DE, Dillbeck MC, Schanbacher V, Dillbeck SL, Gallois P, Beall-Rougerie S, Schneider RH, Nidich SI, Kaplan GP, Belok S. A double blind randomized controlled trial of Maharishi Vedic vibration technology in subjects with arthritis. Frontiers in Bioscience. 2001;6:H7–H17. DOI: 10.2741/A720. PMID: 11282569.
Read the complete published study
View the study record and abstract on PubMed
View the article through its DOI
The Raj offers personalized Ayurvedic programs designed to support joint comfort, mobility, digestion, circulation, stress reduction, and overall balance.
Each guest’s program is selected according to their individual needs and may include Ayurvedic consultations, personalized Panchakarma treatments, specialized herbalized oils, Ayurvedic meals, daily routine guidance, and time for deep rest.
The programs currently offered at The Raj are not the same as the specialized Vedic vibration procedure evaluated in this study. This research is presented as part of the broader body of research associated with the Vedic approach to health.
This information is provided for educational purposes and is not intended to diagnose, treat, cure, or prevent arthritis or any other disease. Individual experiences and results vary. Do not begin, delay, change, or discontinue medical treatment or prescribed medication without consulting a qualified healthcare professional.
A published study conducted at The Raj found that a five-day Panchakarma program was associated with a 46% reduction in PCBs and a 58% reduction in beta-HCH, two persistent fat-soluble environmental toxicants.
An 11-year analysis of Blue Cross/Blue Shield data found 63% lower medical expenditures, 80% fewer hospital admissions, and 55% fewer outpatient visits among Maharishi Ayurveda participants compared with normative data and controls.
A published case series followed four patients with Parkinson’s disease, sarcoidosis, renal hypertension, and diabetes with hypertension and anxiety, reporting improvements after a comprehensive Ayurvedic program.
Research on comprehensive Ayurvedic rejuvenation programs has reported reductions in certain fat-soluble toxicants, improvements in cardiovascular and stress-related markers, and measurable changes in brain activity during Shirodhara.
A double-blind randomized study of 176 adults with chronic arthritis reported immediate improvements in pain, stiffness, and range of motion following a specialized Vedic vibration treatment, with nearly three-quarters reporting at least 60% pain relief.
A randomized controlled study of 127 older adults with mild hypertension found that Transcendental Meditation reduced systolic blood pressure by 10.7 mm Hg and diastolic pressure by 6.4 mm Hg compared with a lifestyle education control.
Research exploring how Vedic sound frequencies may influence the body’s natural self-regulating mechanisms, including a laboratory study that found lower average cell growth with Sama Veda.